StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MEDX.SW$8.88-0.66%
Fair $8.88+0.0%

MEDX.SW

medmix AG

Industrials / Specialty Industrial MachinerySwiss

$8.88

-0.06 (-0.66%)

Fairly Valued+0.0%Fair Value $8.88Fund rank 31/100 · Data gapFallback financials|
SA 33/D
F-Score: 6/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 26% · confianza 25%

FCF escenarios

weak_data · normalized FCF $26.7M · quality 57.0/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 52/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

33/100

D

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years ROE is 1.5%, below the 5% threshold
Thesis & Journal · MEDX.SWLocal privado en este navegador · medmix AG
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$361M

P/E

59.2x

↑

EV/EBITDA

8.2x

↓

ROE

1.5%

↓

Gross Margin

36.1%

↑

Debt/Equity

0.78

↑
52-Week Range$9
$8$13

TradingView lightweight chart

MEDX.SW price, volumen y niveles de valoración

Último $9.040Periodo -79.5%
Fair value: $8.880

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-2.1%

FCF CAGR

+43.7%

FCF margin

6.0%

FCF / Net income

4.17x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $448.0M · net income $6.4M · FCF $26.7M

2022-FY → 2025-FY

Gross margin

36.1%-0.6% pts

Operating margin

6.2%-4.2% pts

Net margin

1.4%-1.0% pts

FCF margin

6.0%+4.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$448.0M$448.0M$483.9M$486.6M$477.1M
Net Income$6.4M$6.4M$-7.4M$300000.00$11.6M
EBITDA$75.2M$75.2M$67.3M$71.4M$69.7M
EPS0.150.15-0.180.010.28
Gross Margin36.1%36.1%33.0%32.4%36.8%
Operating Margin6.2%6.2%3.7%2.9%10.4%
Net Margin1.4%1.4%-1.5%0.1%2.4%
Balance Sheet
Debt/Equity0.780.780.740.750.94
Current Ratio1.541.54———
Cash Flow
Free Cash Flow$26.7M$26.7M$38.1M$3.2M$9.0M
Returns
ROE1.5%1.5%-1.7%0.1%2.3%
Valuation
P/E59.2059.20—1848.0063.93
EV/EBITDA8.208.209.0013.9912.85
P/B0.870.870.871.641.46
Growth & Yield
Revenue Growth-7.4%-7.4%-0.6%2.0%—
EPS Growth183.3%183.3%-1900.0%-96.4%—
Dividend Yield1.1%1.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

73.8%

muy exigente

EPS terminal req.

$0.79

Spread vs growth

109.5%

5Y implied EPS CAGR

44.8%

muy exigente

EPS terminal req.

$0.95

Spread vs growth

138.6%

10Y implied EPS CAGR

26.2%

muy exigente

EPS terminal req.

$1.54

Spread vs growth

157.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -4.7%

Total return

-4.7%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.18 → 0.15

Residual

-5.8%

EPS growthn/d
Multiple reratingn/d
Dividend+1.1%
Residual / FX / buybacks / cross-term-5.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.